Intercept Pharmaceuticals
ICPT
#5462
Rank
$0.79 B
Marketcap
$19.00
Share price
0.00%
Change (1 day)
-7.90%
Change (1 year)

Operating Margin for Intercept Pharmaceuticals (ICPT)

Operating Margin as of March 2024 (TTM): -59.02%

According to Intercept Pharmaceuticals 's latest financial reports and stock price the company's current Operating Margin is -59.02%. At the end of 2021 the company had an Operating Margin of -25.15%.

Operating Margin history for Intercept Pharmaceuticals from 2012 to 2023

Operating Margin at the end of each year

Year Operating Margin Change
2021-25.15%-71.39%
2020-87.91%-35.73%
2019-136.78%-20.47%
2018-171.99%-37.5%
2017-275.18%-83.37%
2016-1,654.56%-79.67%
2015-8,139.07%-49.95%
2014-16,262.23%289%
2013-4,180.52%134.31%
2012-1,784.19%132.87%
2011-766.17%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
24.66%-141.78%๐Ÿ‡บ๐Ÿ‡ธ USA
26.84%-145.48%๐Ÿ‡บ๐Ÿ‡ธ USA
19.24%-132.60%๐Ÿ‡บ๐Ÿ‡ธ USA
-250.93% 325.16%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.